3745131|t|Baclofen treatment in a patient with tardive dystonia.
3745131|a|The use of baclofen, a structural analog of gamma-aminobutyric acid (GABA), is described in the treatment of a patient with tardive dystonia. The patient, a woman with a clinical diagnosis of Alzheimer's disease, developed tardive dystonia after 8 weeks of haloperidol therapy and experienced complete remission of her dystonia while taking baclofen 60 mg/day. This case suggests that baclofen may facilitate remission of tardive dystonia in some cases and provides a basis for further investigation.
3745131	0	8	Baclofen	Chemical	MESH:D001418
3745131	24	31	patient	Species	9606
3745131	37	53	tardive dystonia	Disease	MESH:D000071057
3745131	66	74	baclofen	Chemical	MESH:D001418
3745131	99	122	gamma-aminobutyric acid	Chemical	MESH:D005680
3745131	124	128	GABA	Chemical	MESH:D005680
3745131	166	173	patient	Species	9606
3745131	179	195	tardive dystonia	Disease	MESH:D000071057
3745131	201	208	patient	Species	9606
3745131	212	217	woman	Species	9606
3745131	247	266	Alzheimer's disease	Disease	MESH:D000544
3745131	278	294	tardive dystonia	Disease	MESH:D000071057
3745131	312	323	haloperidol	Chemical	MESH:D006220
3745131	374	382	dystonia	Disease	MESH:D004421
3745131	396	404	baclofen	Chemical	MESH:D001418
3745131	440	448	baclofen	Chemical	MESH:D001418
3745131	477	493	tardive dystonia	Disease	MESH:D000071057
3745131	Positive_Correlation	MESH:D006220	MESH:D000071057
3745131	Negative_Correlation	MESH:D001418	MESH:D004421
3745131	Negative_Correlation	MESH:D006220	MESH:D000544
3745131	Negative_Correlation	MESH:D006220	MESH:D004421
3745131	Negative_Correlation	MESH:D001418	MESH:D000071057
3745131	Comparison	MESH:D001418	MESH:D005680

